OPKO Health’s BioReference Laboratories launched COVID-19 testing program for New York City schools
On Oct. 9, 2020, OPKO Health subsidiary BioReference Labs, New York City, the Department of Health, New York City Health and Hospital Corporation, the Test & Trace Corp, and the Department of Education, announced they will perform COVID-19 molecular testing for NYC schools. In addition, BioReference is collecting specimens from principals, teachers, administration and students from over 950 schools across NYC.
Tags:
Source: OPKO Health
Credit: